Home
About Us
About Maxmind
Corporate Philosophy
Core Advantages
Group Companies
Products
Meiji Seika
Miyarisan
Meiji Pharma (Shantou)
WELDING
RAFARM
Chemo
Macleods
Stanchy
In-house
Upcoming
Join Us
Training and Development
Recruitment
News
Contact Us
Contact Us
Message
中
/
EN
/
Buy Now
Tmall Official Flagship Store
JD.com Self-Operated Flagship Store
Xiaohongshu Official Flagship Store
Meituan Official Flagship Store
WeChat Mall
中
/
EN
/
Home
About Us
About Maxmind
Corporate Philosophy
Core Advantages
Group Companies
Products
Meiji Seika
Miyarisan
Meiji Pharma (Shantou)
WELDING
RAFARM
Chemo
Macleods
Stanchy
In-house
Upcoming
Join Us
Training and Development
Recruitment
News
Contact Us
Contact Us
Message
News
Home
>
News
News
一图看懂近三年被CDE年度审评报告“划重点”的品种
转自:
医药地理
作者:
焦萌萌
Back
Previous:
【喜讯】我公司多个进口注册药品获得国家药监局受理....
Next:
盘点PD-1/PD-L1肺癌免疫新药、靶向新药及....
28
2020-03
Source:美享生物科技(海南)有限公司
最新新闻
Latest NEWS
12
2025.12
五一劳动节,致敬每一位劳动者
12
2025.12
美享医药致敬最美白衣天使!
12
2025.12
端午至,寓安康
12
2025.12
【喜讯】欧盟进口的他达拉非片(商标名“刚戈”)获批上市
12
2025.12
【喜讯】我公司取得乙酰麦迪霉素干混悬剂的MAH批件
12
2025.12
【喜讯】我公司取得地喹氯铵含片的MAH批件
12
2025.12
应用广泛的极化液
12
2025.12
我公司拟进口的阿仑膦酸钠片已向NMPA提交资料
12
2025.12
欢度中秋,与君同行